--%>

ICGI Articles

  • DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance

    Published: 14.09.2024

    Cyll K, Skaaheim Haug E, Pradhan M, Vlatkovic L, Carlsen B, Löffeler S, Kildal W, Skogstad K, Hauge Torkelsen F, Syvertsen RA, Askautrud HA, Liestøl K, Kleppe A, Danielsen HE

    Br J Cancer, 131 (5), 895-904

    PubMed 38961192

  • Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?

    Published: 06.04.2024

    Kenseth A, Kantorova D, Seo MK, Aas E, Cairns J, Kerr D, Askautrud H, Jacobsen JE

    Pharmacoeconomics, 42 (6), 679-691

    PubMed 38584239

  • PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer

    Published: 28.08.2021

    Cyll K, Kleppe A, Kalsnes J, Vlatkovic L, Pradhan M, Kildal W, Tobin KAR, Reine TM, Wæhre H, Brennhovd B, Askautrud HA, Skaaheim Haug E, Hveem TS, Danielsen HE

    Cancers (Basel), 13 (17)

    PubMed 34503100

  • MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer

    Published: 20.09.2020

    Hillestad T, Hompland T, Fjeldbo CS, Skingen VE, Salberg UB, Aarnes EK, Nilsen A, Lund KV, Evensen TS, Kristensen GB, Stokke T, Lyng H

    Cancer Res, 80 (18), 3993-4003

    Pubmed 32606004

  • Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer

    Published: 16.12.2019

    Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2019)

    Int J Cancer

    PubMed 31846064

  • Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer

    Published: 03.12.2019

    Ersvær E, Kildal W, Vlatkovic L, Cyll K, Pradhan M, Kleppe A, Hveem TS, Askautrud HA, Novelli M, Wæhre H, Liestøl K, Danielsen HE

    Mod Pathol Dec 4 2019

    PubMed 31801961

  • Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage

    Published: 15.08.2019

    Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN

    Br J Cancer. 2019 Sep;121(6):474-482.

    PubMed 31388185

  • Chromatin organisation and cancer prognosis: a pan-cancer study

    Published: 31.01.2018

    Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE

    Lancet Oncol DOI: https://doi.org/10.1016/S1470-2045(17)30899-9

    PubMed 29402700

  • Prognostic markers for colorectal cancer; estimating ploidy and stroma

    Published: 26.12.2017

    Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ

    Ann Oncol

    PubMed 29293881

  • Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma

    Published: 21.06.2017

    Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)

    Virchows Arch

    PubMed 28643014

  • « 1 2 3 Previous Next » 

Chief Editor: Tarjei S. Hveem, Interim Institute Director
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20